The Management of Prostate Cancer with Very High PSA (Prostatic Specific Antigen)

来源 :2013第六届世界癌症大会 | 被引量 : 0次 | 上传用户:luckkycaroll
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  It is commonly believed that prostate cancer patients with very high prostate-specific antigen (PSA) levels are unlikely to benefit from definitive local treatment, and patients with very high PSA are often underrepresented in randomized clinical trials.A registry-based analysis of 6449 patients without nodal or distant metastases diagnosed from 1990 to 2001 was performed.
其他文献
MicroRNAs (miRNA) have been implicated in nasopharyngeal carcinoma (NPC), a highly invasive and metastatic cancer that is widely prevalent in southern China.We found that miR-26a is commonly downregul
会议
Head and neck cancer patients are suffering from dysphagia, malnutrition and alterations of swallowing and taste in nearly 100 %.Nearly 75% of them are already malnourished before starting their antic
会议
Oral cancer has been identified as a significant public health threat worldwide.Clinically, oral cancer is characterized by locoregional recurrence and poor survival.Thus, the novel molecular markers
会议
Background: Synovial cell sarcomas represent a rare group of cancers, particularly in the head and neck region.Furthermore, only a few cases of retropharyngeal and laryngeal synovial cell sarcomas hav
会议
Many human cancers develop by following many different pathways.These cancers include lung cancer, colon cancer, liver cancer, skin cancer, cutaneous melanoma, and renal cancer (adult kidney cancer).I
Colorectal cancer (CRC) is the third most prevalent cancer in both men and women worldwide.Progression to CRC, similar to other cancers, is a multistep process, often with a background of genomic inst
会议
From the first analysis of immuneprecipitation followed by Western blotting Corin and TLP seem to precipitate at the same height (approximately 50KDa) and are recognized by the same antibodies.Concurr
会议
Patients with non-small cell lung cancer (NSCLC) who have activating epidermal growth factor receptor (EGFR) mutations benefit from treatment with EGFR-tyrosine kinase inhibitors ((EGFRTKIs), namely g
会议
Part Ⅰ: We reviewed local-regional recurrence for 175 cases with esophageal squamous cell carcinoma after Three-field lymph node dissection (3-FLD) without Prophylactic radiotherapy from 2005 to 2010
会议
The purpose of this paper is to present a case of sinonasal carcinoma in the sphenoid sinus that extends into the nasopharynx.Sinonasal carcinomas are unusual and make up less then 3% of the tumors fo
会议